Kestra Medical Technologies (NASDAQ:KMTS – Get Free Report) is one of 511 publicly-traded companies in the “Healthcare Equipment & Supplies” industry, but how does it weigh in compared to its rivals? We will compare Kestra Medical Technologies to related businesses based on the strength of its institutional ownership, earnings, risk, profitability, valuation, analyst recommendations and dividends.
Analyst Ratings
This is a breakdown of recent recommendations for Kestra Medical Technologies and its rivals, as reported by MarketBeat.com.
| Sell Ratings | Hold Ratings | Buy Ratings | Strong Buy Ratings | Rating Score | |
| Kestra Medical Technologies | 1 | 2 | 5 | 0 | 2.50 |
| Kestra Medical Technologies Competitors | 4314 | 10603 | 18404 | 838 | 2.46 |
Kestra Medical Technologies presently has a consensus price target of $29.00, suggesting a potential upside of 2.57%. As a group, “Healthcare Equipment & Supplies” companies have a potential upside of 23.35%. Given Kestra Medical Technologies’ rivals higher possible upside, analysts plainly believe Kestra Medical Technologies has less favorable growth aspects than its rivals.
Insider and Institutional Ownership
Valuation and Earnings
This table compares Kestra Medical Technologies and its rivals gross revenue, earnings per share (EPS) and valuation.
| Gross Revenue | Net Income | Price/Earnings Ratio | |
| Kestra Medical Technologies | $95.13 million | -$131.61 million | -10.59 |
| Kestra Medical Technologies Competitors | $1.90 billion | $137.78 million | 5.72 |
Kestra Medical Technologies’ rivals have higher revenue and earnings than Kestra Medical Technologies. Kestra Medical Technologies is trading at a lower price-to-earnings ratio than its rivals, indicating that it is currently more affordable than other companies in its industry.
Volatility and Risk
Kestra Medical Technologies has a beta of 0.45, meaning that its share price is 55% less volatile than the S&P 500. Comparatively, Kestra Medical Technologies’ rivals have a beta of 2.68, meaning that their average share price is 168% more volatile than the S&P 500.
Profitability
This table compares Kestra Medical Technologies and its rivals’ net margins, return on equity and return on assets.
| Net Margins | Return on Equity | Return on Assets | |
| Kestra Medical Technologies | -140.43% | -63.83% | -44.76% |
| Kestra Medical Technologies Competitors | -300.70% | -179.63% | -22.71% |
Summary
Kestra Medical Technologies rivals beat Kestra Medical Technologies on 9 of the 13 factors compared.
About Kestra Medical Technologies
Kestra Medical Technologies is a medical technology company focused on wearable solutions for people at risk of sudden cardiac arrest. Its products combine cardiac monitoring, treatment technology and digital services intended to support patients and their care teams. The company’s flagship product, the ASSURE wearable cardioverter defibrillator, continuously monitors a patient’s heart rhythm and can deliver a treatment shock if it detects a life-threatening arrhythmia. The system also provides alerts and supports remote sharing of patient data with clinicians.
Receive News & Ratings for Kestra Medical Technologies Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Kestra Medical Technologies and related companies with MarketBeat.com's FREE daily email newsletter.
